Abstract: Compounds of the formula: ##STR1## wherein Z is sulfur or oxygen; R is alkyl of 1 to 7 carbon atoms; R.sup.1 is aryl of 6 to 10 carbon atoms, lower alkyl of 1 to 6 carbon atoms or cycloalkyl of 3 to 8 carbons, all optionally substituted with 1 to 3 halogen atoms; a is 0 or 1; b is 0, 1, or 2; X is independently halo, nitro, trihalomethyl, lower alkyl of 1 to 3 carbon atoms, or lower alkoxy of 1 to 3 carbon atoms are useful as fungicides and insecticides.
Abstract: Disclosed herein are a derivative of tetrahydrobenzothiazole represented by the formula (I): ##STR1## wherein R represents a hydrogen atom, a hydroxyl group or a lower acyloxy group such as acetoxy group and propionyloxy group and X represents a methylene group, C.sub.1 to C.sub.4 -alkylamino group, benzylamino group or --O--, and a herbicidal composition containing the same as an active ingredient.
Abstract: 1,2-Benzoxathiine derivatives of the formula I ##STR1## wherein Hal is chlorine, bromine or iodine,R is hydrogen, halogen, nitro, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 haloalkyl, cyano or a --X--R.sup.1, --CO--X--R.sup.2, --CO--NR.sup.3 R.sup.4, --SO--R.sup.5 or --SO.sub.2 --R.sup.6 group, whereR.sup.1 is C.sub.3 -C.sub.5 alkynyl, or is C.sub.1 -C.sub.4 alkyl, unsubstituted or substituted by halogen or C.sub.1 -C.sub.4 alkoxy, or is C.sub.3 -C.sub.5 alkenyl, unsubstituted or substituted by halogen or C.sub.1 -C.sub.4 alkoxy,R.sup.2 and R.sup.5 are each independently of the other C.sub.1 -C.sub.4 alkyl,-C.sub.1 -C.sub.4 haloalkyl, C.sub.2 -C.sub.4 alkoxyalkyl, C.sub.3 -C.sub.5 alkenyl, C.sub.3 -C.sub.5 alkynyl, phenyl or benzyl,R.sup.3 and R.sup.4 are each independently of the other hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 haloalkyl, C.sub.2 -C.sub.4 alkoxyalkyl, C.sub.3 -C.sub.5 alkenyl, C.sub.3 -C.sub.5 alkynyl, phenyl or benzyl, R.sup.6 is C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.
Abstract: The invention is phosphono-s-triazines corresponding to the formula ##STR1## wherein: X is separately in each occurrence chlorine, bromine, haloalkyl or alkyl;Y is separately in each occurrence hydrogen, chlorine or bromine;R is separately in each occurrence hydrogen, hydrocarbyl, CH.sub.2 Y, CH.sub.2 OH or CH.sub.2 OC(R.sup.1).sub.3 wherein R.sup.1 is alkyl;a is an integer from 0 to 2 inclusive; andb is an integer from 1 to 3 inclusive, with the proviso that the sum of a and b equal 3, and with the further proviso that at least one R is CH.sub.2 OH or CH.sub.2 OC(R.sup.1).sub.3.
Abstract: Disclosed herein are a derivative of tetrahydrobenzothiazole represented by the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 represent respectively a straight chain alkyl group having 1 to 6 carbon atoms or a branched chain alkyl group having 1 to 6 carbon atoms, and a herbicidal composition containing the same as an active ingredient.
Abstract: Certain enol ether derivatives of oxicams (1,1-dioxides of N-heteroaryl-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamides and N-heteroaryl-4-hydroxy-2-methyl-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamid es) are useful as prodrugs of these antiinflammatory compounds.
Abstract: Novel heterobicyclic compounds of Formula I, processes for preparing same and pesticidal compositions and methods are described.
Type:
Grant
Filed:
April 18, 1983
Date of Patent:
October 22, 1985
Assignee:
SDS Biotech Corporation
Inventors:
Thomas A. Magee, Robert D. Battershell, Lawrence E. Limpel, Andrew W. Ho, Arthur W. Friedman, H. Glenn Corkins, William W. Brand, Russell Buchman, Louis Storace, Edmond R. Osgood
Abstract: Compounds of formula (I): ##STR1## wherein: Ar is phenyl optionally substituted in the o-, m- or p-position by C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl, bromo, chloro or fluoro,pyrryl optionally N-substituted by C.sub.1-4 alkyl,2-furyl or 2-thienyl either optionally substituted in the 3-, 4- or 5-position by methyl, chloro or bromo, or3-furyl or 3-thienyl;X is oxygen, sulphur, sulphoxide or sulphone, Y is methylene, R.sub.1 and R.sub.3 are hydrogen or C.sub.1-4 alkyl, and R.sub.2 is hydrogen, C.sub.1-4 alkyl, fluoro, chloro or bromo, or X is methylene, Y is oxygen, R.sub.1 and R.sub.3 are both hydrogen, and R.sub.2 is hydrogen, fluoro, chloro or bromo; andR.sub.4 is hydrogen or C.sub.1-4 alkyl, or a salt thereof, have analgesic and/or anti-inflammatory activity.
Type:
Grant
Filed:
February 17, 1984
Date of Patent:
October 22, 1985
Assignee:
Beecham Group p.l.c.
Inventors:
Robert W. Ward, Stephen A. Smith, Roger E. Markwell
Abstract: A process for preparing certain phosphite-isocyanurate oligomers. The process requires the reaction of a trishydroxyalkyl isocyanurate with a tris-organophosphite and, optionally, an alcohol or alkylphenol. The process is promoted by an alkaline catalyst such as sodium methoxide. The oligomeric product is useful as a thermal stabilizer in polymer compositions.
Abstract: 4-Hydroxy-2-methyl-3-(2-pyridylcarbamoyl)-6-trifluoromethyl-2H-thieno[2,3-e ]-1,2-thiazine 1,1-dioxide of the formula ##STR1## and its pharmaceutically acceptable salts which possess valuable pharmacodynamic properties are described. More particularly, the compound and its salts display antiinflammatory, analgesic and antirheumatic activities and they are readily accessible by reacting a corresponding alkyl ester with 2-aminopyridine and, if desired, subsequent salt formation.
Type:
Grant
Filed:
August 31, 1983
Date of Patent:
October 1, 1985
Assignee:
Hoffmann-La Roche Inc.
Inventors:
Rudolf Pfister, Paul Zeller, Dieter Binder, Otto Hromatka
Abstract: A series of novel 4-piperidino-6,7-dimethoxyquinazoline compounds, further substituted on the piperidino group, and the pharmaceutically-acceptable salts thereof, possess cardiac stimulating activity in mammals. They are useful in the curative or prophylactic treatment of cardiac conditions, in particular heart failure.
Type:
Grant
Filed:
July 31, 1984
Date of Patent:
September 17, 1985
Assignee:
Pfizer Inc.
Inventors:
Simon F. Campbell, Albert A. Jaxa-Chamiec, David A. Roberts
Abstract: The invention relates to novel tropone derivatives, of antiinflammatory, analgesic and antirheumatic activity, of the formula: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl,R.sup.2 is hydrogen, hydroxy, halogen, lower alkyl, or lower alkoxy, andR.sup.3 is hydrogen or acyl,and pharmaceutically acceptable salts thereof.
Abstract: The invention provides new derivatives of the formula: ##STR1## in which either (a) Y=COOH or a radical of the formula (II), in which R.sub.2 =alkyl or benzyl, A=a sulphur atom, m=1, n=0, R=pyridin-3-yl and R.sub.1 =H, or (b) Y=CN, COOH or a radical of the formula ##STR2## defined as above, A=S, O or CH.sub.2, m=1 or 2 and n=0, 1 or 2, (m+n) being 1, 2 or 3, R=H, alkyl or phenyl (optionally substituted by halogen, alkyl, alkoxy or CF.sub.3) and R.sub.1 =a radical of the formula ##STR3## in which p=0 or 1, the alkyl radicals and alkyl portions being straight-chain or branched-chain and containing 1 to 4 carbon atoms each. Processes for the production of these compounds are described. They are useful as intermediates for the preparation of new medicaments.
Type:
Grant
Filed:
January 11, 1984
Date of Patent:
September 3, 1985
Assignee:
Rhone-Poulenc Sante
Inventors:
Jean-Louis Fabre, Daniel Farge, Claude James, Daniel Lave
Abstract: 1-(2-Aryl-2-halo-1-ethenyl)-1H-azoles having anticonvulsant properties which are particularly useful in the treatment of generalized forms of epilepsy.
Abstract: Polyisocyanato-polyisocyanurates are prepared by catalytically cyclotrimerizing a polyisocyanate in the presence of a catalytically effective amount of an aminosilyl catalyst, and which is characterizing by terminating the cyclotrimerization reaction when a predetermined desired amount of isocyanurate groups has been obtained, by adding to the reaction mixture a reaction terminating amount of an organic catalyst deactivating compound comprising at least one free hydroxyl moiety, or the reaction product of such hydroxylated organic catalyst deactivating compound with an isocyanate.
Abstract: Novel benzo[b]thiophenes, compositions containing same, process for the preparation thereof and methods of reducing blood pressure and producing diuresis by administration of the compounds and compositions are disclosed.
Abstract: The invention relates to new 2-cyanobenzimidazole derivatives.These compounds correspond to the formula (I): ##STR1## in which: n is 0, 1, 2 or 3,R is halogen; optionally halogen-substituted lower alkyl or alkylthio; lower alkoxy optionally substituted by one or more halogens or by the phenyl radical; lower alkenyl; lower alkynyl; amino optionally substituted by one or two alkyls; NO.sub.2 --; CN--; CNO--; NCS--; , SCN--; lower alkylsulphonyl; sulphamoyl optionally substituted by one or two alkyls; lower alkylsulphinyl; optionally substituted acyl; or alkoxycarbonyl, andR' is optionally halogen-substituted lower alkyl, amino optionally substituted by one or two alkyl radicals, or a nitrogen atom substituted by two radicals forming a heterorcyclic ring with this nitrogen atom, the heterocyclic ring containing from 4 to 6 ring members and from 1 to 3 hetero-atoms in the ring.They can be used in agriculture, in particular for combating phytopathogenic fungi and for combating mites.
Abstract: The title compounds correspond to the formula ##STR1## wherein A is a monovalent, bivalent, trivalent or tetravalent radical of a mono-, di-, tri- or tetraamine. These compounds are useful as stabilizers for organic polymers and lubricating oils to counteract the degradative effects of heat, light and air.
Type:
Grant
Filed:
November 21, 1983
Date of Patent:
August 13, 1985
Assignee:
Ciba-Geigy Corporation
Inventors:
David H. Steinberg, Raymond Seltzer, John J. Luzzi, Frank P. Cortolano
Abstract: The invention provides 2-(3,5-disubstituted pyridylalkyl amino)-5-pyridylmethyl-4-pyrimidone derivatives which are useful as histamine H.sub.1 -antagonists.
Type:
Grant
Filed:
February 2, 1984
Date of Patent:
August 13, 1985
Assignee:
Smith Kline & French Laboratories Limited
Abstract: Object of the invention is a class of new organic compounds derived from 1,4-benzothiazine through substitution of an hydrogen atom in position 6, 7 or 8 by an oxypropanolammine radical monosubstituted in N and furthermore a series of new phenyl derivatives of 1,4-benzothiazine, obtained as intermediate in the synthesis of oxypropanolammine derivatives, and process for obtained the new compounds in form suitable for the preparation of pharmaceutical compositions having antihypertensive, vasodilating and antiarrhythmic activity.